Taurus LLC, Human Serum Albumin, Recombinant Human Albumin, Pharmaceutical Excipient, Albumin for cell culture - Taurus LLC - GTC has formed a joint venture with Fresenius to expand the commercial development opportunities of GTC's recombinant human albumin (rhA) program. The joint venture will manage development of rhSA for both the blood expander market and for the use of rhA in the excipient market.


	Taurus hSA LLC Taurus is a joint venture of GTC Biotherapeutics and Fresenius-Kabi. This business venture is in place to develop, manufacture and market recombinant human albumin (rhA) for pharmaceutical excipient and selected cell culture applications. For information regarding Taurus, please contact: transgenicsinfo@gtc-bio.com Back to Recombinant Human Albumin Page
	Copyright 2006 GTC Biotherapeutics, All Rights Reserved